ChromosOmics - Database


Icon by Leon Liehr             

                                                     - CHROMOSOME 11 -                                                    
- paternal UPD -

UPD MATERNAL
 CHR . 11

UPD unclear if maternal or paternal
 CHR . 11
UPD-cases without clinical findings
+ normal karyotype
UPD-cases with or unclear clinical
correlation + normal karyotype

UPD-cases without clinical findings
+ balanced karyotype
UPD-cases with or unclear clinical
correlation
+ balanced karyotype
UPD-cases without clinical findings
+ sSMC
UPD-cases with or unclear clinical
correlation + sSMC

segmental UPD-cases without
clinical findings

segmental UPD-cases with or
unclear clinical correlation 
UPD-cases without clinical findings
+ other imbalances
UPD-cases with or unclear clinical
correlation + other imbalances
References


pat UPD-cases without clinical findings + normal karyotype

case no.
gender
age at diagnosis
studied
material

GTG-banding result
clinical symptoms
reference
11-
OpU-N/

1-1
- - - - - -

mosaic cases
case no.
gender
age at diagnosis
studied
material

GTG-banding result
clinical symptoms
reference
11-
OpU-N/
mos/

1-1
- - - - - -


pat UPD-cases without clinical findings + balanced karyotype

case no.
gender
age at diagnosis
studied
material

GTG-banding result
clinical symptoms
reference
11-
OpU-bal/
1-1

- - - - - -


pat UPD-cases without clinical findings + sSMC

case no.
case no. in sSMC database
gender/
age at diagnosis

studied
material

GTG-banding result
final FISH result of the sSMC
FISH
methods

clinical symptoms
reference
11-
OpU-sSMC/
1-1

- - - - - - - -


segmental pat UPD-cases without clinical findings

case no.
gender
age at diagnosis
studied
material

GTG-banding result
clinical symptoms
reference
11-
OpU-seg/
p15.4/

1-1 to 1-2
female
32 to 35 y
PBL
n.a.
---
pat UPD 11 in 11p15.4 (gene TH01)
normal females
but infertile due to partial or complete hydatic mole

{1145}
11-
OpU-seg/
p15.4/

1-3
female
~32 y
PBL
n.a.
---
pat UPD 11 in 11p15.4 (gene TH01)
normal female with gestational trophoblastic neoplasia
but infertile due to partial or complete hydatic mole

{1145}

mosaic cases
case no.
gender
age at diagnosis
studied
material

GTG-banding result
clinical symptoms
reference
11-
OpU-seg/
/
mos/

1-3
- - - - - -


pat UPD-cases without clinical findings + other imbalances

case no.
gender
age at diagnosis
studied
material

GTG-banding result clinical symptoms
reference
11-
OpU-imb/

1-1

- - - - - -

mosaic cases
case no.
gender
age at diagnosis
studied
material

GTG-banding result
clinical symptoms
reference
11-
OpU-imb/
mos/

1-1

- - - - - -


pat UPD-cases with or unclear clinical correlation + normal karyotype
review on BWS see {835}; in BWS due to UPD(11)pat developing hyperinsulinaemic hypoglycaemia
require near-total pancreatectomy - maybe sirolimus treatment may help as well {939}
Also enhanced cancer risk in BWS-patients in general and specifically in such with UPD(11)pat {1233}
Acc. to {1279} all BWS cases diseased due to UPD are mosaics.
For general review on BWS see also {1382 and 1383}.
Acc. to {1594} BWS patients with
UPD(11)pat having narrower mouths while imprinting center loss lads to wider tongues and mouths.
{1600} state that BWS patient with UPD(11)pat have higher reoperation rates of macroglossia than others.


case no.
gender
age at diagnosis
studied
material

GTG-banding result
clinical symptoms
reference
11-
WpU-N/
1-1 to 1-14
n.a.
postnatal
PBL
n.a.
Beckwith-Wiedemann-syndrome (BWS)
{129}
11-
WpU-N/
1-15 to 1-18
n.a.
postnatal
PBL
n.a.
BWS
{139} cases 49-52
{140}

11-
WpU-N/
1-19
n.a.
postnatal
PBL
n.a.
BWS
{285}
11-
WpU-N/
1-20
n.a.
postnatal
PBL
n.a.
BWS
{610} 1 case
11-
WpU-N/
1-21
male
postnatal
PBL
n.a.
BWS (and hepatoblastoma)
{616}
11-
WpU-N/
1-22 to 1-23
n.a.
postnatal
PBL
n.a.
BWS
{638}
11-
WpU-N/
1-24 to 1-119
n.a.
postnatal
PBL
n.a.
BWS
{640} 96 cases; in {679} 41 of those cases
11-
WpU-N/
1-120 to 1-131
n.a.
postnatal
PBL
n.a.
BWS
{654; 672} 11 cases
11-
WpU-N/
1-132 to 185
n.a.
postnatal
PBL
n.a. BWS
{672; 674} 54 cases
11-
WpU-N/
1-186 to 1-188

n.a.
postnatal
PBL
n.a.
BWS
{766} cases 2 to 4
11-
WpU-N/
1-189 to 1-269

n.a.
postnatal
PBL
n.a.
unclear if segmental!!

BWS
{780} 81 cases
11-
WpU-N/
1-270

n.a.
postnatal
PBL
n.a.
BWS
{804} 1 case
11-
WpU-N/
1-271

n.a.
postnatal
PBL
n.a.
BWS
{808}
11-
WpU-N/
1-272 to 1-406

n.a.
postnatal
PBL
n.a.
BWS
{835} 135 cases
11-
WpU-N/
1-407

n.a.
postnatal
PBL
n.a.
BWS
{843} 1 case
11-
WpU-N/
1-408 to 1-430

n.a.
postnatal
PBL
n.a.
BWS
{654; 672; 674; 871;943} 22 cases
11-
WpU-N/
1-431 to 1-442

n.a.
postnatal
PBL
n.a.
BWS
{881} 12 cases
11-
WpU-N/
1-443

n.a.
postnatal
PBL
n.a.
BWS
{889} 1 case
11-
WpU-N/
1-444 to 1-452

n.a.
postnatal
PBL
n.a.
BWS
{969} 9 cases
11-
WpU-N/
1-453 to 1-454

n.a.
postnatal
PBL
n.a.
BWS
{985} 2 cases
11-
WpU-N/
1-455 to 1-456

n.a.
prenatal
AF
n.a.
BWS
{1098} 2 cases
11-
WpU-N/
1-457

n.a.
newborn
PBL
n.a.
BWS
{1123}
11-
WpU-N/
1-458

n.a.
child
PBL
n.a.
BWS
{1205} 1 case
11-
WpU-N/
1-459

n.a.
child
PBL
n.a.
BWS
{1250} 1 case
11-
WpU-N/
1-460 to 1-497

n.a.
postnatal
PBL
n.a.
BWS
{1270; 1271} overall 38 cases
11-
WpU-N/
1-498 to 1-505

n.a.
postnatal
PBL
n.a.
BWS
{1292} 8 cases
11-
WpU-N/
1-506 to 1-507

n.a.
postnatal
PBL
n.a.
BWS
{1353} cases 1 to 2
11-
WpU-N/
1-508 to 1-517

n.a.
postnatal
PBL
n.a.
BWS
{1355} 10 cases
11-
WpU-N/
1-518 to 1-529

n.a.
postnatal
PBL
n.a.
BWS
{1360} 12 cases
11-
WpU-N/
1-530

female
postnatal
PBL
n.a.
BWS
{1388}, case 1
11-
WpU-N/
1-531 to 1-541

n.a.
postnatal
PBL
n.a.
BWS
{1413} 11 cases
11-
WpU-N/
1-542

female
4m
PBL
n.a.
BWS
{1430}
11-
WpU-N/
1-543

male
1y
PBL
n.a.
BWS
and Wilms tumor
{1467}
11-
WpU-N/
1-544

n.a.
postnatal
PBL
n.a.
BWS
and Wilms tumor
{1475}
11-
WpU-N/
1-545 to 1-558

10 male
3 female
postnatal
PBL
n.a.
BWS
{1527} 13 cases
11-
WpU-N/
1-559

female
prenatal
AF
46,XY
BWS; TOP
{1528} case 25
11-
WpU-N/
1-560 to 1-562

n.a.
postnatal
PBL
n.a.
BWS
{1580} 3 cases
11-
WpU-N/
1-563 to 1-577

n.a.
postnatal
PBL
n.a.
BWS
{1594} 15 cases
11-
WpU-N/
1-578 to 1-581

n.a.
postnatal
PBL
n.a.
BWS
{1600} 4 cases
11-
WpU-N/
1-582 to 1-617

n.a.
postnatal
PBL
n.a.
BWS
{1605} 36 cases
11-
WpU-N/
2-1

male
postnatal
PBL
n.a.
focal BWS and ß-thalassemia
(gene
HBB in 11p15.4)
{84}
11-
WpU-N/
3-1 to 3-4
n.a.
postnatal
PBL
46,XN
UPD only proven for band 11p15
focal form of neonatal hyperinsulinism (gene ABCC8 in 11p15.1)
{146} 4 cases
11-
WpU-N/
4-1 to 5-2

n.a.
postnatal
PBL, tongue
n.a.
UPD11 only in tongue not in blood detected

BWS
{794} 2 cases
11-
WpU-N/
5-1 to 5-4

n.a.
postnatal
PBL
n.a.
BWS
{947} cases 17, 128, 220, 227b}
11-
WpU-N/
6-2 to 6-3

n.a. newborn
PBL
46,XN
UPD only proven for band 11p15 and mosaic
BWS and congenital hyperinsulinism and hemihypertrophy
(gene
KCNJ11 in 11p15.1)
{1386} cases 8 and 9
11-
WpU-N/
7-1 to 7-4

n.a.
postnatal, children PBL
n.a.
no BWS but Cushing  syndrome in one of 4 and all with adrenocortical tumors
{1353} cases 3-6

mosaic cases
case no.
gender
age at diagnosis
studied
material

GTG-banding result
clinical symptoms
reference
11-
WpU-N/
mos/
1-1 to 1-2

n.a.
postnatal
PBL
n.a.
UPD in mosaic - not specified

BWS
{1304} 2 cases
11-
WpU-N/
mos/
1-3

female
postnatal
PBL
46,XX
acc to mol. genet. result mosaic of cells with and without pat UPD
BWS
{157} case 3
11-
WpU-N/
mos/
1-4

female
postnatal
PBL; different tissues
n.a.
acc to mol. genet. result mosaic of cells with and without pat UPD
BWS
{224}
11-
WpU-N/
mos/
  1-5 to 1-6

n.a.
postnatal
PBL
n.a.
10-20% only with UPD
BWS
{713} cases KvDMR and H19DMR
11-
WpU-N/
mos/
1-7


female

postnatal
PBL
n.a.
90% only with UPD

BWS
{935} case 21-006
11-
WpU-N/
mos/
1-8 to 1-13

n.a.
postnatal
PBL
n.a.
mosaic of UPD

BWS
{955} cases 10-14; 25
11-
WpU-N/
mos/
1-14

female
5m
PBL
n.a.
mosaic of UPD 11
only 11p15.5 region tested

BWS
{1117}
11-
WpU-N/
mos/
1-15

n.a.
newborn
PBL
n.a.
mosaic of UPD 11
only 11p15.5 region tested

BWS
{1150}
11-
WpU-N/
mos/
1-16

n.a.
newborn
PBL
n.a.
mosaic of UPD 11
only 11p15.5 region tested

BWS
{1339} 1 case
11-
WpU-N/
mos/
1-17 to 1-28

n.a.
postnatal
after IVF

PBL
n.a.
mosaic of UPD 11
unclear which  region tested

BWS
{1406} 12 cases
11-
WpU-N/
mos/
1-29 to 1-33

n.a.
postnatal
PBL
n.a.
mosaic of UPD 11
unclear which  region tested

BWS
{1440} 5 cases
11-
WpU-N/
mos/
1-34

female
2m
PBL
n.a.
mosaic of UPD 11
unclear which  region tested

BWS
{1491}
11-
WpU-N/
2-1 to 2-5
n.a.
postnatal
PBL
46,XN
UPD only proven for band 11p15 and mosaic
focal form of neonatal hyperinsulinism (gene ABCC8 in 11p15.1)
{1386} cases 1-5
11-
WpU-N/
3-1 to 3-2

n.a. newborn
PBL
46,XN
UPD only proven for band 11p15 and mosaic
BWS and congenital hyperinsulinism and hemihypertrophy
(gene
KCNJ11 in 11p15.1)
{1386} cases 8 and 9


pat UPD-cases with or unclear clinical correlation+ balanced karyotype

case no.
gender
age at diagnosis
studied
material

GTG-banding result
clinical symptoms
reference
11-
WpU-bal/
1-1
-
-
-
-
-
-


pat UPD-cases with or unclear clinical findings + sSMC

case no.
case no. in sSMC database
gender/
age at diagnosis

studied
material

GTG-banding result
final FISH result of the sSMC
FISH
methods

clinical symptoms
reference
11-
WpU-sSMC/
1-1

- - - - - - - -


segmental pat UPD-cases with or unclear clinical correlation

case no.
gender
age at diagnosis
studied
material

GTG-banding result
clinical symptoms
reference
11-
WpU-seg/
1-1 to 10
n.a.
postnatal
PBL
n.a.
---
pat UPD 11 in LIT tested
BWS
{579} 6 cases from 'validation group' and 4 from 'practice group'
11-
WpU-seg/
1-11 to 1-18

n.a.
postnatal
PBL
n.a.
---
pat UPD 11 (at least in 11p15)

BWS
{798} 8 cases
11-
WpU-seg/
1-19

female
1m
PBL
n.a.
---
pat UPD 11 (at least in 11p15)

BWS
{939}
11-
WpU-
seg/
pter/

1-1 to 1-2
n.a.
postnatal
PBL
n.a.
---
11pter to 11p15.5
BWS
{139} cases 1-2
{140}

11-
WpU-

seg-pter/
1-3 to 1-4
n.a.
postnatal
PBL
46,XN
---
11pter to 11p15.5
BWS
{609} cases 6-7
11-
WpU-seg/
pter/
1-5

female
16y
PBL and fibroa-denoma
n.a.
---
11pter to 11p15.5

BWS
{861}
11-
WpU-seg/
pter/
1-6 to 1-7

n.a.
postnatal
n.a.
n.a.
---
11pter to 11p15.5

BWS after ART
{1012} 2 cases
11-
WpU-seg/
pter/
1-8

n.a.
postnatal
PBL; hepato-blastoma
n.a.
---
11pter to 11p15.5

BWS
{1030}
11-
WpU-
seg/
pter/

2-1 to 1-12
n.a.
postnatal
PBL
n.a.
---
11pter to 11p15.4
BWS
{139} cases 3-14
{140}

11-
WpU-
seg/
pter/

3-1 to 3-5
n.a.
postnatal
PBL
n.a.
---
11pter to 11p15.1
BWS
{139} cases 15-19
{140}

11-
WpU-
seg/
pter/

4-1 to 4-2
2 female
prenatal
AF
46,XX
---
11pter to 11p15
BWS; omphalocoele, TOP
{195} 2 cases
11-
WpU-
seg/
pter/

5-1
n.a.
postnatal
PBL
n.a.
---
11pter to 11p14.3
ß-thalassemia major evolution from ß-thalassemia minor
(gene
HBB in 11p15.4)
{498}
11-
WpU-
seg/
pter/

6-1 to 6-8
n.a.
postnatal
PBL
n.a.
---
11pter to 11p14
BWS
{139} cases 20-27
{140}

11-
WpU-
seg/
pter/

6-9 to 6-12
n.a.
postnatal
PBL
46
---
11pter to 11p14
BWS, Wilmstumor
{208} 4 cases
{209} 2 cases

11-
WpU-
seg/
pter/

6-13
male
postnatal
PBL
46,XY
---
11pter to 11p14
BWS; permanent neonatal diabetes, hemihypertrophy (gene ABCC8 in 15p15.1)
{325}
11-
WpU-
seg/
pter/

6-14
n.a.
postnatal
PBL
n.a.
---
11pter to 11p14
BWS
{348} family 5
{351; 349}

11-
WpU-
seg/
pter/

6-15
n.a.
postnatal
PBL
46,XN
---
11pter to 11p14
BWS
{609} case 8
11-
WpU-
seg/
pter/

6-16
n.a.
postnatal
PBL
n.a.
---
11pter to 11p14
BWS
{619} case 37
11-
WpU-
seg/
pter/

7-1
male
newborn
PBL
46,XY
---
11pter to 11p14~13
BWS
{106}
11-
WpU-
seg/
pter/

8-1 to 8-8
n.a.
postnatal
PBL
n.a.
---
11pter to 11p13
BWS
{139} cases 28-35
{140}

11-
WpU-
seg/
pter/
8-9 to 8-14
3 male, 3 female
postnatal
PBL
46,XX or 46,XY
---
11pter to 11p13
BWS
{157} cases 1-2 and 4-7
11-
WpU-
seg/
pter/

8-15
n.a.
postnatal
PBL
46,XN
---
11pter to 11p13
BWS
{609} case 5
11-
WpU-
seg/
pter/

9-1
n.a.